KTTA · Pasithea Therapeutics Corp. · Executive Compensation
Market Cap
$14.73M
Shares
33.41M
Volume · Oct 8
56.16K
Avg daily vol (3M)
226.37K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Tiago Reis Marques | Chief Executive Officer | $1,327,518 |
| Dr. Tiago Reis Marques | Chief Executive Officer | $1,327,518 |
| Daniel Schneiderman | Chief Financial Officer | $895,187 |
| Graeme Currie | — | — |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Dr. Tiago Reis Marques | Chief Executive Officer | $640,059 |
| Tiago Reis Marques | Chief Executive Officer | $640,059 |
| Chief Development | Officer | $434,811 |
| Daniel Schneiderman | Chief Financial Officer | $430,223 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Dr. Tiago Reis Marques | Chief Executive Officer | $537,347 |
| Tiago Reis Marques | Chief Executive Officer | $537,347 |
| Graeme Currie | Chief Development Officer | $444,864 |
| Daniel Schneiderman | Chief Financial Officer | $345,939 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Dr. Tiago Reis Marques | Chief Executive Officer | $539,250 |
| Tiago Reis Marques | Chief Executive Officer | $539,250 |
| Daniel Schneiderman | Chief Financial Officer | $367,203 |
| Graeme Currie | Chief Development Officer | $198,870 |
| Stanley M. Gloss | Former Chief Financial Officer | $60,000 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Dr. Tiago Reis Marques | Chief Executive Officer | $671,891 |
| Tiago Reis Marques | Chief Executive Officer | $671,891 |
| Stanley M. Gloss | Former Chief Financial Officer | $412,165 |
| Daniel Schneiderman | Chief Financial Officer | — |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Stanley M. Gloss | Chief Financial Officer | — |
| Tiago Reis Marques | Chief Executive Officer | — |
| Dr. Tiago Reis Marques | Chief Executive Officer | — |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Kartik Krishnan | Chief Medical Officer | Appointed | 2026-05-04 |
| Simon Dumesnil | Class II director | Appointed | 2025-09-03 |
| Alfred Novak | Class II director | Appointed | 2025-09-03 |
| Alfred Novak | director | Appointed | 2023-12-19 |
| Emer Leahy | director | Appointed | 2023-12-19 |
| Simon Dumesnil | director | Appointed | 2023-12-19 |
| Lawrence Steinman | director | Appointed | 2023-12-19 |
| Tiago Reis Marques | director | Appointed | 2023-12-19 |
| Daniel Schneiderman | Chief Financial Officer | Appointed | 2022-10-12 |
| Alfred J. Novak | audit committee | Appointed | 2022-09-20 |
| Alfred J. Novak | the Board | Appointed | 2022-09-20 |
| Dr. Lawrence Steinman | Board's audit committee | Resigned | 2022-09-20 |
| Dr. Yassine Bendiabdallah | board of directors | Resigned | 2022-09-20 |